By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today reported that its fourth-quarter revenues declined 16 percent year over year, missing analysts' consensus estimate.

The Cincinnati-based diagnostics firm brought in total revenues of $35.5 million for the three months ended Sept. 30, compared to $42.5 million for the fourth quarter of 2009. It missed analysts' consensus estimate of $38.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.